Why and how to measure urinary sex steroid metabolites in epidemiological studies in women

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 10, Issue 2, 2000, Pages 85-91

  Muti, P ^a   Deutsch, A ^a,b   Freudenheim, J ^a   Bolelli, G ^c   Hill, L ^a   Trevisan, M ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; ARTICLE; BIOLOGICAL RHYTHM; BREAST TUMOR; CHRONIC DISEASE; EPIDEMIOLOGY; FEMALE; HUMAN; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PILOT STUDY; PREMENOPAUSE; RISK FACTOR; SINGLE BLIND PROCEDURE; UNITED STATES; URINALYSIS; URINE;

ADULT; BIOLOGICAL CLOCKS; BREAST NEOPLASMS; CHRONIC DISEASE; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEW YORK; PILOT PROJECTS; PREMENOPAUSE; RISK FACTORS; SINGLE-BLIND METHOD; STEROIDS; URINALYSIS;

EID: 0034168066     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Zumoff B (1989) Hormonal profile in women with breast cancer. Anticanc Res 8:627-636
2. Key TJ, Pike MC (1988) The role of estrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29-13
3. Thomas HV, Reeves GK, Key TJA (1997) Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes and Control 8: 922-928
4. Wilcox A, Baird D, Weinberg CR, Armstrong EG, Musey PI, Wehmann RE, Canfield RE (1987) The use of biochemical assays in epidemiologic studies of reproduction. Envir Health Perspect 75: 29-35
5. Gorgels WJMJ, v.d.Graaf Y, Blankenstein MA, Collette HJA, Erkelens DW, Banga JD (1997) Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: a nested case-referent study in the DOM-Cohort. J Clin Epidemiol 50: 275-281
6. Lemon HM, Wotiz HH, Parsons L, Mozden PJ (1966) Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. JAMA 196: 1128-1136
7. Marmoston J, Crowley LG, Myers SM, Stern E, Hopkins CE. II. (1965) Urinary excretion of estrone, estradiol, and estriol by patients with breast cancer and benign breast disease. Am J Obstet Gynecol 92: 460-467
8. Groenroos M, Aho AJ (1968) Estrogen metabolism in postmenopausal women with primary and recurrent breast cancer. Eur J Cancer 4: 523-527
9. Persson BH, Risholm L (1964) Oophorectomy and cortisone treatment as a method of eliminating oestrogens production in patient with breast cancer. Acta Endocrinol 47: 15-26
10. Argüelles AE, Poggi UL, Saborida C, Hoffman C, Chekherdemian M, Blanchard O (1973) Endocrine profiles and breast cancer. Lancet I: 165-168
11. Grattarola R, Secreto G, Recchione C, Castellini W (1974) Androgens and breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. Am J Obstet Gynecol 118: 173-178
12. Berstein L, Ross RK, Pike MC, Brown JB, Henderson BE (1990) Hormone levels in older women: a study of postmenopausal breast cancer patients and healthy population controls. Br J Cancer 61: 298-302
13. Morreal CE, Dao TL, Nemoto T, Lonergan PA (1979) Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer. JNCI 63: 1171-1174
14. Key TA, Wang DY, Brown JB (1996) A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer 73: 1615-1619
15. Thijssen JH, Poortmann J, Schwarz F (1975) Androgens in postmenopausal breast cancer: excretion, production and interaction with estrogens. J Steroid Biochem 6: 729-734
16. Liu K, Stamler J, Dyer A, McKeever J, Mckeever P (1977) Statistical methods to assess and minimize the role of intra-individual variability in obscuring the relationship between dietary lipids and serum cholesterol. J Chron Dis 31: 399-418
17. Muti P, Trevisan M, Micheli A, Krogh V, Bolelli G, Sciajno R, Berrino F (1996) Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 5: 917-922
18. Kleinbaum DG, Kupper LL, Morgenstern H (1982)Information Bias. In: Kleinbaum DG, Kupper LL, Morgenstern H (eds), Epidemiologic research-principles and quantitative methods. Van Nostrand Reinold Company, New York, pp. 220-236
19. Denari JH, Farinati Z, Casas PR, Oliva A (1981) Determination of ovarian function using first morning urine steroid assays. Obstet Gynecol 58: 5-9
20. Collins WP, Branch CM, Collins PO (1981) Ovulation prediction and detection by the measurement of steroid glucuronides. In: Cortes-Prieto J, Campos De Paz A., Neves-e-Castro M (eds), Research on fertility and sterility. MTP Press Ltd., Lancaster, England, pp. 19-33
21. Chatterton Jr. RT, Haan JN, Jenco JM, Cheesman KL (1982) Radioimmunoassay of pregnandiol concentration in early morning urine specimens for assessment of luteal function in women. Fertil Steril 37: 361-366
22. Fleiss JL (1986) Reliability of measurements. In: Fleiss JL (ed), The design and analysis of clinical experiments., John Wiley & Sons, New York, pp. 1-14
23. Statistical Package for Social Sciences (Windows version 7.5) Chicago, Illinois, 1997.
24. Collins WP, Collins PO, Kilpatrick MJ, Manning PA, Pike JM, Tyler JPP (1979) The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3-glucuronide as indices of ovarian function. Acta Endocrinol 90: 336-348
25. Kolata G (1984) A new kind of epidemiology. Science 24:481
26. Lasley BL, Shideler SE (1994) Methods for evaluating reproductive health of women. Occup Med 9: 423-433
27. Panico S, Pisani P, Muti P, Recchione C, Covelleri A, Totis A, Berrino F (1990) Diurnal variation of testosterone and estradiol: a source of bias in comparative studies on breast cancer. J Endocrinol Invest 13: 423-426